GB2331460A - Pharmaceutical composition for the treatment of hepatitis B comprising extract of phyllanthus ussuriensis and/or phyllanthus urinaria - Google Patents

Pharmaceutical composition for the treatment of hepatitis B comprising extract of phyllanthus ussuriensis and/or phyllanthus urinaria

Info

Publication number
GB2331460A
GB2331460A GB9903338A GB9903338A GB2331460A GB 2331460 A GB2331460 A GB 2331460A GB 9903338 A GB9903338 A GB 9903338A GB 9903338 A GB9903338 A GB 9903338A GB 2331460 A GB2331460 A GB 2331460A
Authority
GB
United Kingdom
Prior art keywords
phyllanthus
hepatitis
extract
pharmaceutical composition
ussuriensis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB9903338A
Other versions
GB2331460B (en
GB9903338D0 (en
Inventor
Tai Ho Chung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEPAGUARD CO Ltd
Original Assignee
HEPAGUARD CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEPAGUARD CO Ltd filed Critical HEPAGUARD CO Ltd
Publication of GB9903338D0 publication Critical patent/GB9903338D0/en
Publication of GB2331460A publication Critical patent/GB2331460A/en
Application granted granted Critical
Publication of GB2331460B publication Critical patent/GB2331460B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Abstract

An extract of Phyllanthus ussuriensis or Phyllanthus urinaria which shows a therapeutic activity for hepatitis B is used in formulating a pharmaceutical composition for treating hepatitis B.
GB9903338A 1996-08-16 1996-08-16 Pharmaceutical composition for the treatment of hepatitis B comprising extract of phyllanthus ussuriensis and/or phyllanthus urinaria Expired - Fee Related GB2331460B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR1996/000135 WO1998007437A1 (en) 1996-08-16 1996-08-16 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEPATITIS B COMPRISING EXTRACT OF PHYLLANTHUS USSURIENSIS AND/OR $i(PHYLLANTHUS URINARIA)

Publications (3)

Publication Number Publication Date
GB9903338D0 GB9903338D0 (en) 1999-04-07
GB2331460A true GB2331460A (en) 1999-05-26
GB2331460B GB2331460B (en) 1999-12-22

Family

ID=19449053

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9903338A Expired - Fee Related GB2331460B (en) 1996-08-16 1996-08-16 Pharmaceutical composition for the treatment of hepatitis B comprising extract of phyllanthus ussuriensis and/or phyllanthus urinaria

Country Status (3)

Country Link
JP (1) JP3249136B2 (en)
GB (1) GB2331460B (en)
WO (1) WO1998007437A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200100642T2 (en) 1998-08-25 2001-07-23 Yale University Prevention and treatment of helioxanthin and its analogs, hepatitis B virus and flavivirus.
WO2000027413A1 (en) * 1998-11-11 2000-05-18 Hepaguard Co., Ltd. Pharmaceutical composition for the treatment of hepatitis b comprising corilagin or brevifolin carboxylic acid
AU6013400A (en) * 2000-06-16 2001-12-24 Balakrishnan Arun Lignan compounds with antiproliferative properties
DE10120627A1 (en) 2001-04-26 2002-10-31 Cmi Ag Use of phyllanthus components for the treatment or prophylaxis of infections caused by hepatitis B viruses
KR101559301B1 (en) 2014-02-25 2015-10-12 강원대학교산학협력단 A composition comprising the Phyllanthus urinaria extract and the compound isolated therefrom for preventing and treating enterovirus-or Coxsackievirus involved diseases
WO2019193381A1 (en) * 2018-04-05 2019-10-10 Thi Trieu NGUYEN Composition for treating hepatitis b

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0199429A2 (en) * 1985-04-26 1986-10-29 Fox Chase Cancer Center Manufacture of a medicament for treating viral hepatitis
US5529778A (en) * 1994-09-13 1996-06-25 Rohatgi; Surendra Ayurvedic composition for the prophylaxis and treatment of AIDS, flu, TB and other immuno-deficiencies and the process for preparing the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0199429A2 (en) * 1985-04-26 1986-10-29 Fox Chase Cancer Center Manufacture of a medicament for treating viral hepatitis
US5529778A (en) * 1994-09-13 1996-06-25 Rohatgi; Surendra Ayurvedic composition for the prophylaxis and treatment of AIDS, flu, TB and other immuno-deficiencies and the process for preparing the same

Also Published As

Publication number Publication date
GB2331460B (en) 1999-12-22
JP3249136B2 (en) 2002-01-21
JP2000511928A (en) 2000-09-12
WO1998007437A1 (en) 1998-02-26
GB9903338D0 (en) 1999-04-07

Similar Documents

Publication Publication Date Title
AU1577792A (en) Implantation tissue and treatment and use methods
ZA90171B (en) Treatment methods and vaccines for stimulating an immune response
EP0589825A3 (en) Ophthalmologic examination and/or treatment apparatus.
GB9609932D0 (en) Use of IL-12 and IFN alpha for the treatment of infectious diseases
HU9602310D0 (en) Urease-based vaccine and treatment for helicobacter infection
NO891896D0 (en) PROCEDURE AND DEVICE FOR TREATMENT OF MEDICAL SPECIAL WASTE.
DK0527879T3 (en) Synergistic therapeutic preparations and methods.
PH31600A (en) Methods of inhibiting atrophy of the skin and vagina.
IL96915A0 (en) Method and apparatus for fragmentation of hard substances within the human body
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
PL297849A1 (en) Vaccine against and method of treating the patients infectedwith hiv virus
NZ287385A (en) Antigenic preparation comprising the catalase of helicobacter bacteria and vaccines used to treat helicobacter infection
GR1002802B (en) Cosmetic compositions and skin treatment compositions
HU9202095D0 (en) Therapy and vaccine against aids
OA09658A (en) Materials and methods for the treatment of foreign tissue
GB2331460A (en) Pharmaceutical composition for the treatment of hepatitis B comprising extract of phyllanthus ussuriensis and/or phyllanthus urinaria
EP0369216A3 (en) Pharmaceutical preparation based on ester derivatives of hecogenine, and their use in treating benign prostatic hyperplasia
GB2211389B (en) Procedure for the treatment of pigs in slaughterhouses, and system for the stalling of pigs
HUP9800829A3 (en) Collagen-based methods and formulations for the treatment of immune system-mediated diseases
AU1898792A (en) Treatment or therapeutic booth for energetic, cosmetic and medical purposes
SG50419A1 (en) Methods of therapeutic and anaesthetic treatment and preparations therefor
GEP20012489B (en) Use of Natural Human α-Interferon
EP0403530A4 (en) Storage-stable compositions and methods for treating keratinous tissue
GB8804531D0 (en) Skin treatment formulations
ZA93211B (en) Enzyme castration of animals and tumor treatment.

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20060816